Cediranib (AZD2171) in Patients with Advanced Hepatocellular Carcinoma: A Phase II North Central Cancer Treatment Group (NCCTG) Clinical Trial

Por Alberts, Steven R., Fitch, Tom R., Kim, George P., Morlan, Bruce W., Dakhil, Shaker R., Gross, Howard M., Nair, Suresh
Publicado em 2012

Prevention of Pegfilgrastim-Induced Bone Pain: A Phase III Double-Blind Placebo-Controlled Randomized Clinical Trial of the University of Rochester Cancer Center Clinical Community...

Por Kirshner, Jeffrey J., Heckler, Charles E., Janelsins, Michelle C., Dakhil, Shaker R., Hopkins, Judith O., Coles, Charlotte, Morrow, Gary R.
Publicado em 2012

Prevention of Delayed Nausea: A University of Rochester Cancer Center Community Clinical Oncology Program Study of Patients Receiving Chemotherapy

Por Roscoe, Joseph A., Heckler, Charles E., Morrow, Gary R., Mohile, Supriya G., Dakhil, Shaker R., Wade, James L., Kuebler, J. Philip
Publicado em 2012

Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: A URCC CCOP study of 576 patients

Por Ryan, Julie L., Heckler, Charles E., Roscoe, Joseph A., Dakhil, Shaker R., Kirshner, Jeffrey, Flynn, Patrick J., Hickok, Jane T., Morrow, Gary R.
Publicado em 2011

Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)

Por Loprinzi, Charles L., Qin, Rui, Dakhil, Shaker R., Fehrenbacher, Louis, Flynn, Kathleen A., Atherton, Pamela, Seisler, Drew, Qamar, Rubina, Lewis, Grant C., Grothey, Axel
Publicado em 2014

Phase 2 Study of Pemetrexed plus Carboplatin, or Pemetrexed plus Cisplatin with Concurrent Radiation Therapy Followed by Pemetrexed Consolidation in Patients with Favorable-Prognos...

Por Choy, Hak, Schwartzberg, Lee S., Dakhil, Shaker R., Garon, Edward B., Gerber, David E., Choksi, Janak K., Govindan, Ramaswamy, Peng, Guangbin, Koustenis, Andrew, Treat, Joseph, Obasaju, Coleman
Publicado no J Thorac Oncol (2013)

Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8

Por Kearns, Ann E., Northfelt, Donald W., Dueck, Amylou C., Atherton, Pamela J., Dakhil, Shaker R., Rowland, Kendrith M., Fuloria, Jyotsna, Flynn, Patrick J., Dentchev, Todor, Loprinzi, Charles L.
Publicado em 2009

Phase III, Randomized, Double-Blind, Placebo-Controlled Evaluation of Pregabalin for Alleviating Hot Flashes, N07C1

Por Loprinzi, Charles L., Qin, Rui, Baclueva, Ernie P., Flynn, Kathleen A., Rowland, Kendrith M., Graham, David L., Erwin, Nancy K., Dakhil, Shaker R., Jurgens, Donald J., Burger, Kelli N.
Publicado em 2010

Zoledronic Acid for Treatment of Osteopenia and Osteoporosis in Women with Primary Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy

Por Hines, Stephanie L., Sloan, Jeff A., Atherton, Pamela J., Perez, Edith A., Dakhil, Shaker R., Johnson, David B., Reddy, Pavan S., Dalton, Robert J., Mattar, Bassam I., Loprinzi, Charles L.
Publicado em 2010

Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation on the Erythropoietic Response to Darbepoetin Alfa for Patients With Chemothera...

Por Steensma, David P., Sloan, Jeff A., Dakhil, Shaker R., Dalton, Robert, Kahanic, Stephen P., Prager, Diane J., Stella, Philip J., Rowland, Kendrith M., Novotny, Paul J., Loprinzi, Charles L.
Publicado em 2011

Prophylactic Tetracycline Does Not Diminish the Severity of Epidermal Growth Factor Receptor (EGFR) Inhibitor Induced Rash: Results from the North Central Cancer Treatment Group (S...

Por Jatoi, Aminah, Dakhil, Shaker R., Sloan, Jeff A., Kugler, John W., Rowland, Kendrith M., Schaefer, Paul L., Novotny, Paul J., Wender, Donald B., Gross, Howard M., Loprinzi, Charles L.
Publicado em 2010

Phase II Trial of Carboplatin, Paclitaxel, Cetuximab and Bevacizumab Followed by Cetuximab and Bevacizumab in Advanced Non-Squamous Non-Small Cell Lung Cancer: SWOG S0536

Por Kim, Edward S., Moon, James, Herbst, Roy S., Redman, Mary W., Dakhil, Shaker R., Velasco, Mario R., Hirsch, Fred R., Mack, Philip C., Kelly, Karen, Heymach, John V., Gandara, David R.
Publicado em 2013

5-year Follow-up of a Randomized Controlled Trial of Immediate versus Delayed Zoledronic Acid for Prevention of Bone Loss in Postmenopausal Women with Breast Cancer Starting Letroz...

Por Wagner-Johnston, Nina D., Sloan, Jeff A., Liu, Heshan, Kearns, Ann E., Hines, Stephanie L., Puttabasavaiah, Suneetha, Dakhil, Shaker R., Lafky, Jacqueline M., Perez, Edith A., Loprinzi, Charles L.
Publicado no Cancer (2015)

Does Sunscreen Prevent Epidermal Growth Factor Receptor (EGFR) Inhibitor–Induced Rash? Results of a Placebo-Controlled Trial from the North Central Cancer Treatment Group (N05C4)

Por Jatoi, Aminah, Thrower, Abby, Sloan, Jeff A., Flynn, Patrick J., Wentworth-Hartung, Nicole Lea, Dakhil, Shaker R., Mattar, Bassam I., Nikcevich, Daniel A., Novotny, Paul, Sekulic, Aleksandar, Loprinzi, Charles L.
Publicado em 2010

Radiotherapy and Adjuvant Trastuzumab in Operable Breast Cancer: Tolerability and Adverse Event Data From the NCCTG Phase III Trial N9831

Por Halyard, Michele Y., Pisansky, Thomas M., Dueck, Amylou C., Suman, Vera, Pierce, Lori, Solin, Larry, Marks, Larry, Davidson, Nancy, Martino, Silvana, Kaufman, Peter, Kutteh, Leila, Dakhil, Shaker R., Perez, Edith A.
Publicado em 2009

Sequential phase II Southwest Oncology Group studies (S0012 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with cyclosporine, in older patients with...

Por Chauncey, Thomas R., Gundacker, Holly, Shadman, Mazyar, List, Alan F., Dakhil, Shaker R., Erba, Harry P., Slovak, Marilyn L., Chen, I-Ming, Willman, Cheryl L., Kopecky, Kenneth J., Appelbaum, Frederick R.
Publicado em 2009

Wisconsin Ginseng (Panax quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind Trial, N07C2

Por Barton, Debra L., Liu, Heshan, Dakhil, Shaker R., Linquist, Breanna, Sloan, Jeff A., Nichols, Craig R., McGinn, Travis W., Stella, Philip J., Seeger, Grant R., Sood, Amit, Loprinzi, Charles L.
Publicado em 2013

Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer

Por Mehta, Rita S., Barlow, William E., Albain, Kathy S., Vandenberg, Ted A., Dakhil, Shaker R., Tirumali, Nagendra R., Lew, Danika L., Hayes, Daniel F., Gralow, Julie R., Livingston, Robert B., Hortobagyi, Gabriel N.
Publicado em 2012

Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124

Por Lara, Primo N., Natale, Ronald, Crowley, John, Lenz, Heinz Josef, Redman, Mary W., Carleton, Jane E., Jett, James, Langer, Corey J., Kuebler, J. Philip, Dakhil, Shaker R., Chansky, Kari, Gandara, David R.
Publicado em 2009

Prospective Multicenter Study of the Impact of Oncotype DX Colon Cancer Assay Results on Treatment Recommendations in Stage II Colon Cancer Patients

Por Srivastava, Geetika, Renfro, Lindsay A., Behrens, Robert J., Lopatin, Margarita, Chao, Calvin, Soori, Gamini S., Dakhil, Shaker R., Mowat, Rex B., Kuebler, J. Philip, Kim, George, Mazurczak, Miroslaw, Lee, Mark, Alberts, Steven R.
Publicado em 2014